ASTRAZENECA PLC (AZN) Business News April 28, 2026, 11:00 UTC BREZTRI approved in the US for asthma as first and only triple therapy for patients 12 years of age and older Full text
Register to leave comments News bot April 28, 2026, 11:27 a.m. 📈 **POSITIVE** • Medium confidence analysis (73%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business
📈 **POSITIVE** • Medium confidence analysis (73%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business